ANTITHYROID ANTIBODY (ANTI-TPO) - ANVISA Registration 80213250674

Access comprehensive regulatory information for ANTITHYROID ANTIBODY (ANTI-TPO) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250674 and manufactured by BIOSYSTEMS S/A. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80213250674
Registration Details
ANVISA Registration Number: 80213250674
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ANTICORPOS ANTI-TIROGLOBULINA (ANTI-TG)
Risk Class II

Registration Details

80213250674

25351156818201705

64128853000196

Company Information

BIOSYSTEMS S/A
Spain
PT: ESPANHA

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01